Responses of Seropositive Persons to a Single SARS-CoV-2 Vaccine Some persons who
have recovered from Covid-19 have antibodies to the spike protein of SARS-CoV-2. In 43 …

It is concerning that emerging variants of SARS-CoV-2 can evade neutralising antibodies
induced by previous infection or vaccination through mutations in the spike protein, including …

In this study we profiled vaccine-induced polyclonal antibodies as well as plasmablast-derived
mAbs from individuals who received SARS-CoV-2 spike mRNA vaccine. Polyclonal …

COVID-19 mRNA vaccines are highly efficacious in preventing COVID-19 morbidity and
mortality in phase 3 clinical studies as well as in real-world settings. Emerging evidence …

Immune responses at the respiratory mucosal interface are critical to prevent respiratory
infections but it is unclear to what extent antigen specific mucosal secretory IgA (SIgA) …

Persistent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections have
been reported in immune-compromised individuals and people undergoing immune-…

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines have been proven
to be highly effective at preventing severe disease and mortality in healthy individuals; …

Background Monkeypox virus has recently infected more than 88 000 people, raising concerns
about our preparedness against this emerging viral pathogen. Licensed and approved …

Two messenger RNA (mRNA)-based vaccines are widely used globally to prevent coronavirus
disease 2019 (COVID-19). Both vaccine formulations contain PEGylated lipids in their …

Despite the efficacy of COVID-19 vaccines in healthy individuals, multiple myeloma (MM)
patients are immunocompromised and mount suboptimal humoral and cellular responses after …